{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:03:09Z","timestamp":1756339389810,"version":"3.44.0"},"reference-count":19,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2018,9,25]]},"abstract":"<jats:p>Guillain-Barr\u00e9 syndrome (GBS) is an immune-mediated polyneuropathy, often preceded by an illness. It is a self-limiting illness in most of the cases, but recurrence is rare and can be seen in about 1%\u20136% of patients. GBS is characterised by progressive, symmetrical, proximal and distal weakness. Areflexia and sensory disturbances are also common. Patients with GBS usually have albuminocytological dissociation on cerebrospinal fluid (CSF) analysis. This is a case of a 69-year-old woman with recurrent GBS and normal CSF findings.<\/jats:p>","DOI":"10.1136\/bcr-2018-226572","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T02:05:10Z","timestamp":1539741910000},"page":"bcr-2018-226572","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["A Rare case of recurrent Guillain-Barr\u00e9 syndrome without albuminocytological dissociation"],"prefix":"10.1136","volume":"2018","author":[{"given":"Anudeep","family":"Yelam","sequence":"first","affiliation":[{"name":"Department of Neurology, University of Missouri Health Care, Columbia, Missouri, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0521-9485","authenticated-orcid":false,"given":"Elanagan","family":"Nagarajan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Howard Hughes Medical Institute\u2014University of Missouri Columbia School of Medicine, Columbia, Missouri, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghav","family":"Govindarajan","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Missouri Health Care, Columbia, Missouri, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5364-4606","authenticated-orcid":false,"given":"Pradeep C","family":"Bollu","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Missouri Health Care, Columbia, Missouri, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,10,16]]},"reference":[{"key":"2025082701514008000_2018.oct16_1.bcr-2018-226572.1","first-page":"24","article-title":"Radiculoneuritis syndrome with hyperalbuminosis of cerebrospinal fluid without cellular reaction. Notes on clinical features and graphs of tendon reflexes. 1916","volume":"150","author":"Guillain","year":"1999","journal-title":"Ann Med Interne"},{"doi-asserted-by":"publisher","key":"2025082701514008000_2018.oct16_1.bcr-2018-226572.2","DOI":"10.1212\/WNL.51.4.1110"},{"doi-asserted-by":"publisher","key":"2025082701514008000_2018.oct16_1.bcr-2018-226572.3","DOI":"10.1136\/jnnp.51.5.613"},{"doi-asserted-by":"publisher","key":"2025082701514008000_2018.oct16_1.bcr-2018-226572.4","DOI":"10.1212\/01.wnl.0000310983.38724.d4"},{"doi-asserted-by":"publisher","key":"2025082701514008000_2018.oct16_1.bcr-2018-226572.5","DOI":"10.1093\/brain\/awt285"},{"doi-asserted-by":"publisher","key":"2025082701514008000_2018.oct16_1.bcr-2018-226572.6","DOI":"10.1056\/NEJMra1114525"},{"key":"2025082701514008000_2018.oct16_1.bcr-2018-226572.7","first-page":"95","article-title":"Recurrent Guillain Barr\u00e9 syndrome","volume":"44","author":"Das","year":"2004","journal-title":"Electromyogr Clin Neurophysiol"},{"doi-asserted-by":"publisher","key":"2025082701514008000_2018.oct16_1.bcr-2018-226572.8","DOI":"10.1093\/brain\/115.4.1093"},{"doi-asserted-by":"publisher","key":"2025082701514008000_2018.oct16_1.bcr-2018-226572.9","DOI":"10.1136\/jnnp.2008.156463"},{"doi-asserted-by":"publisher","key":"2025082701514008000_2018.oct16_1.bcr-2018-226572.10","DOI":"10.1212\/01.wnl.0000167549.09664.b8"},{"key":"2025082701514008000_2018.oct16_1.bcr-2018-226572.11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/mus.21480","article-title":"Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy","volume":"41","author":"Dionne","year":"2010","journal-title":"Muscle Nerve"},{"key":"2025082701514008000_2018.oct16_1.bcr-2018-226572.12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12883-016-0687-z","article-title":"An unusual case of recurrent Guillain-Barr\u00e9 syndrome with normal cerebrospinal fluid protein levels: a case report","volume":"16","author":"Gunatilake","year":"2016","journal-title":"BMC Neurol"},{"key":"2025082701514008000_2018.oct16_1.bcr-2018-226572.13","first-page":"Cd002063","article-title":"Intravenous immunoglobulin for Guillain-Barre syndrome","volume":"1","author":"Hughes","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"2025082701514008000_2018.oct16_1.bcr-2018-226572.14","first-page":"Cd001798","article-title":"Plasma exchange for Guillain-Barre syndrome","volume":"2","author":"Raphael","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"doi-asserted-by":"publisher","key":"2025082701514008000_2018.oct16_1.bcr-2018-226572.15","DOI":"10.1056\/NEJM199204233261705"},{"doi-asserted-by":"publisher","key":"2025082701514008000_2018.oct16_1.bcr-2018-226572.16","DOI":"10.1016\/S0140-6736(96)09095-2"},{"key":"2025082701514008000_2018.oct16_1.bcr-2018-226572.17","first-page":"Cd008630","article-title":"Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barre syndrome","volume":"2","author":"Hughes","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2025082701514008000_2018.oct16_1.bcr-2018-226572.18","doi-asserted-by":"crossref","DOI":"10.1016\/0140-6736(91)91995-7","article-title":"Ineffectiveness of high-dose intravenous methylprednisolone in Guillain-Barr\u00e9 syndrome","volume":"338","author":"Hughes","year":"1991","journal-title":"Lancet"},{"key":"2025082701514008000_2018.oct16_1.bcr-2018-226572.19","first-page":"Cd001446","article-title":"Corticosteroids for Guillain-Barre syndrome","volume":"2","author":"Hughes","year":"2006","journal-title":"Cochrane Database Syst Rev"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-226572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:51:51Z","timestamp":1756284711000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-226572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":19,"alternative-id":["10.1136\/bcr-2018-226572"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-226572","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2018,10,16]]}}}